Tablets containing enrofloxacin and flavouring agents and / or flavours

The formulation of enrofloxacin tablets with lactose, microcrystalline cellulose, and meat flavor, combined with controlled processing, addresses the unpalatability and mechanical issues of existing tablets, resulting in a palatable and effective antibiotic delivery system for animals with enhanced abrasion resistance.

WO2005000275A1 Publication Date: 2005-01-06BAYER HEALTHCARE AG +2
3 Cites 9 Cited by

Patent Information

Application Number
PCT/EP2004/006370
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2003-06-26
Filing Date
2004-06-14
Publication Date
2005-01-06

AI Technical Summary

Technical Problem

Administering tablets containing enrofloxacin to animals is challenging due to their unpalatability, leading to involuntary ingestion and inconsistent drug release when mixed with feed, and adding flavorings often compromises the mechanical properties of the tablets.

Method used

Formulating tablets with 20-45% enrofloxacin, 18-35% lactose, 5-10% microcrystalline cellulose, and 5-20% meat flavor, along with other excipients, which are granulated, dried, and compressed to maintain acceptable mechanical properties and palatability, while using a method that controls residual moisture during drying.

Benefits of technology

The resulting tablets are highly palatable, maintain acceptable mechanical properties, and exhibit high abrasion resistance, ensuring effective and consistent drug delivery in animals, particularly improving palatability and dosage compliance in animal husbandry and veterinary applications.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to tablets for animals, said tablets containing enrofloxacin and flavouring agents and / or flavours.
Need to check novelty before this filing date? Find Prior Art